Ronald Vender

65PUBLICATIONS
125CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)Molecular targetsRheumatology and arthritisHuman impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Jul 03, 2026
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

|May 16, 2026
Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial.

|May 14, 2026
Treatment-associated phenotype switching between psoriasis and atopic dermatitis.

|Apr 16, 2026
Canadian Treat-to-Target Practice Survey of Real-World Interventions and Strategies in Psoriasis (CAN TARGET PSORIASIS).

|Feb 05, 2026
Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study.

Emma Vyvey, Rani Soenen, Hazel H Oon

|Dec 27, 2025
Understanding Cumulative Life Course Impairment in Canadian Patients With Psoriasis.

Jennifer Beecker, Chih-Ho Hong, Hélène Veillette

Pageof 11

Frequent Collaborators

13 joint publications

Melinda J Gooderham

10 joint publications

Tiago Torres

9 joint publications

Kim Parnell

8 joint publications

Vimal H Prajapati